DFP-treated MDS mice also exhibit normalized erythroblast differentiation, expression of Gata1 and Epor (EPO receptor) as well as that of iron chaperones Pcbp1 and Ncoa4, and increased erythroblast ferritin concentration in bone marrow erythroblasts. This evidence concerns the gene PCBP1 and myelodysplastic syndrome.